FOCUS PHARMA (Public limited company)
FOCUS PHARMA is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0846.744.870. It was founded on 19-06-2012. Its registered office is in Leuven. Its main activity is: Wholesale trade. Its annual accounts for 2025 report equity of € -91 912 and a loss of € 20 562. Addrly gives it a financial health grade of D, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 3 financial years.
Information last updated on 07-10-2026.
Company information
Key figures of FOCUS PHARMA
| 2025 | 2024 | 2023 | |
|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -20 562+48 % | € -39 892-138 % | € -16 733 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -91 912-29 % | € -71 350-127 % | € -31 458 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 7 674+84 % | € 4 176-4 % | € 4 356 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -20 000+49 % | € -39 181-149 % | € -15 751 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - | - | - |
Financial estimate
Similar companies
Other companies in the same activity in Leuven.
| Company | Town |
|---|---|
| Funecare | 3001 Leuven |
| SEW-EURODRIVE | 3001 Leuven |
| SIEMENS INDUSTRY SOFTWARE | 3001 Leuven |
| VELOPA | 3001 Leuven |
| Donaldson Europe | 3001 Leuven |
| TERUMO EUROPE | 3001 Leuven |
| CARL ZEISS VISION BELGIUM NV | 3001 Leuven |
| ALBOTEX | 3001 Leuven |
Frequently asked questions
Is FOCUS PHARMA still active? Yes. The Crossroads Bank for Enterprises lists FOCUS PHARMA as active.
What is the VAT number of FOCUS PHARMA? The VAT number of FOCUS PHARMA is BE 0846.744.870.
When was FOCUS PHARMA founded? FOCUS PHARMA was founded on 19-06-2012.
What is the address of FOCUS PHARMA? The current registered office of FOCUS PHARMA is Interleuvenlaan 62, 3001 Louvain.
When did FOCUS PHARMA last file annual accounts? The latest annual accounts of FOCUS PHARMA were filed on 23-07-2026.
Does FOCUS PHARMA file its annual accounts on time? Yes. FOCUS PHARMA filed its annual accounts within the legal deadline for each of its last 3 financial years.
Is FOCUS PHARMA financially healthy? Addrly gives FOCUS PHARMA a financial health grade of D, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is FOCUS PHARMA profitable? The annual accounts of FOCUS PHARMA for 2025 show a loss of € 20 562.
What is the equity of FOCUS PHARMA? The equity of FOCUS PHARMA was € -91 912 at the close of the 2025 financial year.
Who are the directors of FOCUS PHARMA? The annual accounts of FOCUS PHARMA record 3 mandates. The names, roles and dates are visible with a free account.
Can FOCUS PHARMA receive Peppol e-invoices? Yes. FOCUS PHARMA is registered on the Peppol network and can receive structured electronic invoices.
What does FOCUS PHARMA do? The main activity of FOCUS PHARMA is: Wholesale trade.